ImmunoViroTherapy Lab

The IVTLab is an international and interdisciplinary laboratory promoting cutting-edge research in the field of oncoimmunology and immunotherapy using viruses as platforms to induce and/or orchestrate the tumor-specific immune response. The laboratory is well supported and funded by prestigious and internationally recognised funding agencies such as the European Research Council Consolidator grant (ERC-CoG), HiLIFE, Jane and Aatos Erkko Foundation and Tekes.

Twitter and News

@vincersurf

#Pathogens 🦠: Our Allies against #Cancer? sciencedirect.com/science/articl… A new perspective article by #LBuonaguro &… twitter.com/i/web/status/1…

In the last week at work, some of my highlights have been briefly working at our website research content with ERC… twitter.com/i/web/status/1…

Valo Tx CEO Paul G Higham contributed recently to this oncolytic virus therapy article from Labiotech.eutwitter.com/i/web/status/1…

Valo Tx and IVTLab @helsinkiuni is pleased to share a new publication in Molecular Therapy Oncolytics (2021 in pres… twitter.com/i/web/status/1…